Vimarsana
Biggest News Aggregation in the World

Page 5 - Michael Schumann News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michael Schumann. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michael Schumann Today - Breaking & Trending Today

Immunic, Inc. (NASDAQ:IMUX) Q4 2022 Earnings Call Transcript - Vimarsana News

Immunic, Inc. (NASDAQ:IMUX) Q4 2022 Earnings Call Transcript

Jessica Breu: Good morning and welcome to Immunic's Fourth Quarter and Year End 2022 Earnings Call. My name is Jessica Breu, Head of Investor Relations and Communications at Immunic.

Guangming to cooperate with German, French enterprises - Vimarsana News

Guangming to cooperate with German, French enterprises

/PRNewswire/ -- A news report from Shenzhen Daily: During a 10-day business promotion trip to Europe, a delegation from Shenzhen's Guangming District reached...

EQS-News: Immunic to Host Virtual Celiac Disease R&D Day to Highlight Current Pathways for Drug Development and Unmet Medical Need - Vimarsana News

EQS-News: Immunic to Host Virtual Celiac Disease R&D Day to Highlight Current Pathways for Drug Development and Unmet Medical Need

Issuer: Immunic, Inc. / Key word(s): Miscellaneous Immunic to Host Virtual Celiac Disease R&D Day to Highlight Current Pathways for Drug Development and Unmet Medical Need 09.02.2023 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic to Host Virtu...

Immunic to Host Virtual Celiac Disease R&D Day to Highlight Current Pathways for Drug Development and Unmet Medical Need - Vimarsana News

Immunic to Host Virtual Celiac Disease R&D Day to Highlight Current Pathways for Drug Development and Unmet Medical Need

/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused...

Immunic to Participate in Scientific and Investor Conferences in February - Vimarsana News

Immunic to Participate in Scientific and Investor Conferences in February

/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused...